Inflammatory myofibroblastic tumor of right leg and calcified fibroadenoma of left breast removed from a postmenopausal-women: a rare case report and review of literature
DOI:
https://doi.org/10.18203/2349-2902.isj20231979Keywords:
Spindle cell neoplasm, Inflammatory myofibroblastic tumor, Fibroadenoma, Mammography, Exophytic mass, Post menopausal, ImmunohistochemistryAbstract
Inflammatory myofibroblastic tumors are uncommon neoplasms; presentation of these tumors in the lower extremities is extremely rare. Treatment varies depending on type, location and patient factor. Here the case of 60-year-old female post-menopausal (P2L2) presented with swelling over anterior aspect of right leg which was exophytic in nature and left breast lump. Combined histopathology and immunohistochemistry findings favoured myofibroblastic tumor of borderline category- inflammatory myofibroblastic tumor. Mammography of left breast showed presence of fibroadenoma at 12 o’ clock position. Patient underwent wide local excision of right leg swelling followed by split thickness skin grafting and excision of left breast swelling (lumpectomy). Inflammatory myofibroblastic tumors are of varied biologic potentials. They are generally classified as tumours of intermediate biological activity with uncertain malignant potential. There are many factors which affect treatment and prognosis of the patient. Five types of standard treatment for sarcoma are used: surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy. Fibroadenomas are benign breast neoplasms, typically present in women from ages of 20-35 years old (premenopausal).
References
Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surgical Pathol. 2007;31(4):509-20.
Tang TT, Segura AD, Oechler HW. Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children. Cancer. 1990;65(7):1626-34.
Umiker WO, Iverson L. Postinflammatory tumors of the lung; report of four cases simulating xanthoma, fibroma, or plasma cell tumor. J Thoracic Surg. 1954;28(1):55-63.
Wu JP, Yunis EJ, Fetterman G, Jaeschke WF, Gilbert EF. Inflammatory pseudo-tumours of the abdomen: plasma cell granulomas. J Clin Pathol. 1973;26(12):943-8.
Park JH, Kang CH, Kim CH, Chae IJ, Park IJ. Highly malignant soft tissue sarcoma of the extremity with a delayed diagnosis. World J Surg Oncol. 2010;8:84.
Lima M, Di Salvo N, Cordola C, D’Antonio S, Libri M, Maffi M et al. Laparoscopy-assisted versus open surgery in treating intestinal atresia: single center experience. J Invest Surg. 2021;34(8):842-7.
Dubayova T, Van Dijk JP, Nagyova I, Rosenberger J, Havlikova E, Gdovinova Z et al. The impact of the intensity of fear on patient’s delay regarding health care seeking behavior: a systematic review. Int J Public Health. 2010;55(5):459-68.
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease. Elsevier Health Sci. 2014:1069-70.
Hubbard JL, Cagle K, Davis JW, Kaups KL, Kodama M. Criteria for excision of suspected fibroadenomas of the breast. Am J Surg. 2015;209:297-301.
Kuijper A, Mommers EC, van der Wall E, van Diest PJ. Histopathology of fibroadenoma of the breast. Am J Clin Pathol. 2001;115:736-42.
Ramu EM, Houdek MT, Isaac CE, Dickie CI, Ferguson PC, Wunder JS, Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes. SICOT J. 2017;3:20.
Latt LD, Isler MH, Wong C. Formation Médicale Continue, vol 53. 2010.
Musio F, Mozingo D, Otchy DP. Multiple, giant fibroadenoma. Am Surg. 1991;57(7):438-41.
Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B et al. Incidence and management of complex fibroadenomas. AJR Am J Roentgenol. 2008;190:214-8.
